Fig. 3 | Scientific Reports

Fig. 3

From: Cachexia and efficiency of trifluridine/thymidine phosphorylase inhibitor + bevacizumab in metastatic colorectal cancer

Fig. 3

Kaplan-Meier survival curves for the progression-free (a) and overall survival (b) according to the cachexia index based on the skeletal muscle mass index (S-CXI). The low-S-CXI group showed a poorer prognosis in comparison to the high-S-CXI group with regard to progression-free and overall survival (p = 0.012, p = 0.015, respectively).

Back to article page